Resource Logo
CATIE

(CATIE) INFECTION FIGHTERS: Women using fluconazole




 

TreatmentUpdate 72, Vol. 8, No. 8; October 1996

Study details Doctors in the US recruited 323 HIV-infected women who had less than 300 CD4+ cells for this study. One hundred and sixty-two received fluconazole 200 mg/week and 161 received fake fluconazole (placebo). Researchers monitored 50% of subjects for 2 and a half years.

Results Thirteen subjects developed yeast infections; 6 in the fluconazole group and 7 in the placebo group.

REFERENCES: 1. Vasquez JA, Steel-Moore L, Schuman P, et al . Antifungal susceptibility among Candida species recovered from HIV-positive women receiving fluconazole prophylaxis. Abstract LB10.



 


Copyright © 1996 -CATIE, Publisher. All rights reserved to Canadian AIDS Treatment Information Exchange (CATIE) 555 Richmond St. West, Suite 505, Box 1104, Toronto, ON, M5V 3B1 • Phone: 416-203-7122 • Toll Free: 1-800-263-1638 • Fax: 416-203-8284



Information in this article was accurate in October 20, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.